Title:
MEDICINAL AGENT FOR MEDICAL APPLICATIONS, AND METHOD FOR SEARCHING FOR NOVEL MEDICINAL AGENT
Document Type and Number:
WIPO Patent Application WO/2013/022052
Kind Code:
A1
Abstract:
Provided is a medicinal agent for medical applications, which can act on the function of a target cell specifically. The medicinal agent for medical applications comprises: a cell-incorporated substance that can be incorporated into a target cell specifically; and an acting substance that can act on the function of the target cell and is bound to the cell-incorporated substance.
Inventors:
SUZUKI MINAKO (JP)
NAKAHARA TAKA (JP)
ISHIKAWA HIROSHI (JP)
OYAMA AKIHIRO (JP)
NAKAHARA TAKA (JP)
ISHIKAWA HIROSHI (JP)
OYAMA AKIHIRO (JP)
Application Number:
PCT/JP2012/070291
Publication Date:
February 14, 2013
Filing Date:
August 09, 2012
Export Citation:
Assignee:
NIPPON DENTAL UNIVERSITY (JP)
HITACHI ALOKA MEDICAL LTD (JP)
SUZUKI MINAKO (JP)
NAKAHARA TAKA (JP)
ISHIKAWA HIROSHI (JP)
OYAMA AKIHIRO (JP)
HITACHI ALOKA MEDICAL LTD (JP)
SUZUKI MINAKO (JP)
NAKAHARA TAKA (JP)
ISHIKAWA HIROSHI (JP)
OYAMA AKIHIRO (JP)
International Classes:
A61K47/48; A61P21/00; A61P35/00; G01N33/15; G01N33/50
Domestic Patent References:
| WO2009041666A1 | 2009-04-02 |
Foreign References:
| JP2008533203A | 2008-08-21 | |||
| JP2003506417A | 2003-02-18 | |||
| JP2007528899A | 2007-10-18 | |||
| JP2008515915A | 2008-05-15 | |||
| JP2009528340A | 2009-08-06 |
Other References:
SUZUKI,M. ET AL.: "Establishment and characterization of the rhabdomyosarcoma cell line designated NUTOS derived from the human tongue sarcoma: Special reference to the susceptibility of anti-cancer drugs", HUM CELL, vol. 23, no. 2, 2010, pages 65 - 73, XP055115354
See also references of EP 2742956A4
OHI S.: "Characterization, anticancer drug susceptibility and atRA-induced growth inhibition of a novel cell line (HUMEMS) established from pleural effusion of alveolar rhabdomyosarcoma of breast tissue", HUM CELL, vol. 20, 2007, pages 39 - 51
MINAKO SUZUKI ET AL.: "Establishment and characterization of the rhabdomyosarcoma cell line designated NUTOS derived from the human tongue sarcoma: Special reference to the susceptibility of anti-cancer drugs", HUM CELL, vol. 23, 2010, pages 65 - 73
See also references of EP 2742956A4
OHI S.: "Characterization, anticancer drug susceptibility and atRA-induced growth inhibition of a novel cell line (HUMEMS) established from pleural effusion of alveolar rhabdomyosarcoma of breast tissue", HUM CELL, vol. 20, 2007, pages 39 - 51
MINAKO SUZUKI ET AL.: "Establishment and characterization of the rhabdomyosarcoma cell line designated NUTOS derived from the human tongue sarcoma: Special reference to the susceptibility of anti-cancer drugs", HUM CELL, vol. 23, 2010, pages 65 - 73
Attorney, Agent or Firm:
YKI Patent Attorneys (JP)
Patent business corporation YKI international patent firm (JP)
Patent business corporation YKI international patent firm (JP)
Download PDF:
Claims: